Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. News
  7. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-08-17 pm EDT
49.27 USD   -1.18%
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
08:43aModerna - Evidation Enables First of Its Kind Moderna Study to Track COVID Vaccine Response in Real Life
AQ
03:29aGSK shares ease after plaintiff in first Zantac lawsuit drops case
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer, BioNTech Reportedly Strike New Deal With US Government to Deliver Additional Doses of Covid-19 Vaccine, Dow Jones Says

06/29/2022 | 04:48pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE -5.19% 152.04 Delayed Quote.-41.02%
PFIZER, INC. -1.18% 49.27 Delayed Quote.-16.56%
All news about PFIZER, INC.
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
08:43aModerna - Evidation Enables First of Its Kind Moderna Study to Track COVID Vaccine Resp..
AQ
03:29aGSK shares ease after plaintiff in first Zantac lawsuit drops case
RE
12:05aGSK Says First US Plaintiff to Drop Zantac Case
DJ
08/16Plaintiff in first Zantac lawsuit set for trial drops case
RE
08/16Ambrx Biopharma Names Kate Hermans Interim CEO
MT
08/16PFIZER : Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVI..
PU
08/16Pfizer Inc. - Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive ..
AQ
08/16Digital innovations and congress coverage led to an increase in all hub users
AQ
08/15Pfizer CEO tests positive for COVID-19, has mild symptoms
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 102 B - -
Net income 2022 32 675 M - -
Net cash 2022 11 522 M - -
P/E ratio 2022 8,74x
Yield 2022 3,29%
Capitalization 277 B 277 B -
EV / Sales 2022 2,61x
EV / Sales 2023 3,30x
Nbr of Employees 79 000
Free-Float 59,0%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 49,27 $
Average target price 56,53 $
Spread / Average Target 14,7%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-16.56%279 832
JOHNSON & JOHNSON-2.04%440 572
ELI LILLY AND COMPANY14.70%294 849
ROCHE HOLDING AG-16.74%273 886
ABBVIE INC.4.46%252 042
NOVO NORDISK A/S4.73%238 674